Open original FDA record ↗Recall record
- FDA identifier
- Z-1259-2011
- Company in FDA record
- Bio-Rad Laboratories Inc
- FDA classification date
- Feb 15, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The results from the blood device had the occurrence of some ramping baselines on their chromatograms. The ramping baseline can affect quantitation of the blood results.
Source facts
- Action
- The firm, Bio-Rad Laboratories, Inc., sent an "URGENT: MEDICAL DEVICE CORRECTION" letter dated February 5, 2010, to all customers and letter dated February 16, 2010 to subsidiaries via Fed-Ex or by fax. The letter described the product, problem and action to be taken by the customers. The customers were instructed to review there chromatograms form the lots listed and compare them to what documented; follow the noted instructions; destroy reorder packs from the affected lots if a ramping baseline issue is observed, and complete and return the attached CUSTOMER MEDICAL DEVICE CORRECTION RESPONSE FORM via fax to (510) 741-3954, attention: Bio-Rad CSD Regulatory Affairs Department. If you have any questions, please contact your regional Bio-Rad Office or (510)724-7000.
- Initiated
- 2010-02-19
- Root cause
- Nonconforming Material/Component
- Terminated
- 2011-03-03
- Distribution
- Worldwide distribution: USA including states of: OH, MN, SC and VA; and country including: Japan.
- Recall number
- Z-1259-2011
- Recall status
- Terminated
- CDRH record ID
- 89093
- FDA classified
- 2011-02-15
- Recall event number
- 54746